Bayer is a publicly traded company trading on OTC, led by CEO William N. Anderson.
Upcoming earnings announcement for Bayer
Past 12 earnings reports for Bayer
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | $0.18 | — | $13.3BEst: $13.4B | -0.7% | — |
| Nov 12, 2025 | Q3 2025 | $0.17 | — | $11.3BEst: $10.9B | +3.3% | — |
| Aug 6, 2025 | Q2 2025 | $0.35Est: $0.24 | +45.8% | $12.2BEst: $12.0B | +1.3% | — |
| May 13, 2025 | Q1 2025 | $0.65Est: $0.38 | +71.1% | $14.4BEst: $13.4B | +7.9% | — |
| Mar 5, 2025 | Q4 2024 | $0.28Est: $0.26 | +7.7% | $12.5BEst: $11.4B | +10.0% | — |
| Nov 12, 2024 | Q3 2024 | $0.07Est: $0.17 | -58.8% | $11.0BEst: $11.5B | -5.0% | — |
| Aug 6, 2024 | Q2 2024 | $0.25Est: $0.25 | 0.0% | $12.0BEst: $11.9B | +0.7% | — |
| May 14, 2024 | Q1 2024 | $0.77Est: $0.42 | +83.3% | $15.0BEst: $15.9B | -6.0% | — |
| Mar 5, 2024 | Q4 2023 | $0.50Est: $0.45 | +11.1% | $12.8BEst: $13.1B | -2.8% | — |
| Nov 8, 2023 | Q3 2023 | $0.10Est: $0.27 | -63.0% | $11.3BEst: $11.6B | -2.6% | — |
| Aug 8, 2023 | Q2 2023 | $0.33Est: $0.31 | +7.1% | $12.0BEst: $12.6B | -4.2% | — |
| May 11, 2023 | Q1 2023 | $0.79Est: $0.54 | +46.3% | $15.4BEst: $15.9B | -2.8% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.